Thomas Ebensen

Publications

• Mucosal Heterologous Prime/Boost Vaccination Induces Polyfunctional Systemic Immunity, Improving Protection Against
  Frontiers in Immunology. 2020  |   Pubmed ID: 32153562
• Mucosal CD8+ T Cell Responses Induced by an MCMV Based Vaccine Vector Confer Protection Against Influenza Challenge
  PLoS Pathogens. 09, 2019  |   Pubmed ID: 31525249
• Neutral Lipopolyplexes for In Vivo Delivery of Conventional and Replicative RNA Vaccine
  Molecular Therapy. Nucleic Acids. Sep, 2019  |   Pubmed ID: 31446119
• Invariant NKT Cell-Mediated Modulation of ILC1s As a Tool for Mucosal Immune Intervention
  Frontiers in Immunology. 2019  |   Pubmed ID: 31440243
• The STING Activator C-di-AMP Exerts Superior Adjuvant Properties Than the Formulation Poly(I:C)/CpG After Subcutaneous Vaccination with Soluble Protein Antigen or DEC-205-mediated Antigen Targeting to Dendritic Cells
  Vaccine. 08, 2019  |   Pubmed ID: 31320219
• Novel Colloidal Associations of Soyasaponins and Lipid Components (DPPC, Cholesterol) As Potential Adjuvants for Vaccines
  Vaccine. 08, 2019  |   Pubmed ID: 31320217
• The Combination Vaccine Adjuvant System Alum/c-di-AMP Results in Quantitative and Qualitative Enhanced Immune Responses Post Immunization
  Frontiers in Cellular and Infection Microbiology. 2019  |   Pubmed ID: 30838180
• Self-Amplifying Replicon RNA Delivery to Dendritic Cells by Cationic Lipids
  Molecular Therapy. Nucleic Acids. Sep, 2018  |   Pubmed ID: 30195751
• Influenza-Activated ILC1s Contribute to Antiviral Immunity Partially Influenced by Differential GITR Expression
  Frontiers in Immunology. 2018  |   Pubmed ID: 29623077
• Dual Dye In-vivo Imaging of Differentially Charged PLGA Carriers Reveals Antigen-depot Effect, Leading to Improved Immune Responses in Preclinical Models
  European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences. May, 2018  |   Pubmed ID: 29408551
• Mucosal Administration of Cycle-Di-Nucleotide-Adjuvanted Virosomes Efficiently Induces Protection Against Influenza H5N1 in Mice
  Frontiers in Immunology. 2017  |   Pubmed ID: 29033942
• Self-replicating RNA Vaccine Functionality Modulated by Fine-tuning of Polyplex Delivery Vehicle Structure
  Journal of Controlled Release : Official Journal of the Controlled Release Society. Nov, 2017  |   Pubmed ID: 28935594
• Bivalent Mucosal Peptide Vaccines Administered Using the LCP Carrier System Stimulate Protective Immune Responses Against Streptococcus Pyogenes Infection
  Nanomedicine : Nanotechnology, Biology, and Medicine. Nov, 2017  |   Pubmed ID: 28887213
• Type I IFN and Not TNF, is Essential for Cyclic Di-nucleotide-elicited CTL by a Cytosolic Cross-presentation Pathway
  EBioMedicine. Aug, 2017  |   Pubmed ID: 28754303
• Targeted Antigen Delivery to Dendritic Cells Elicits Robust Antiviral T Cell-mediated Immunity in the Liver
  Scientific Reports. Mar, 2017  |   Pubmed ID: 28266658
• Immunization with Tc52 or Its Amino Terminal Domain Adjuvanted with C-di-AMP Induces Th17+Th1 Specific Immune Responses and Confers Protection Against Trypanosoma Cruzi
  PLoS Neglected Tropical Diseases. Feb, 2017  |   Pubmed ID: 28234897
• Self-Replicating RNA Vaccine Delivery to Dendritic Cells
  Methods in Molecular Biology (Clifton, N.J.). 2017  |   Pubmed ID: 27987142
• New Horizons in the Development of Novel Needle-Free Immunization Strategies to Increase Vaccination Efficacy
  Current Topics in Microbiology and Immunology. 2016  |   Pubmed ID: 27370343
• Modeling Influenza Virus Infection: A Roadmap for Influenza Research
  Viruses. Oct, 2015  |   Pubmed ID: 26473911
• Inverse Micellar Sugar Glass (IMSG) Nanoparticles for Transfollicular Vaccination
  Journal of Controlled Release : Official Journal of the Controlled Release Society. May, 2015  |   Pubmed ID: 25795506
• Efficient Nanoparticle-mediated Needle-free Transcutaneous Vaccination Via Hair Follicles Requires Adjuvantation
  Nanomedicine : Nanotechnology, Biology, and Medicine. Jan, 2015  |   Pubmed ID: 25200611
• Pegylated Bisacycloxypropylcysteine, a Diacylated Lipopeptide Ligand of TLR6, Plays a Host-protective Role Against Experimental Leishmania Major Infection
  Journal of Immunology (Baltimore, Md. : 1950). Oct, 2014  |   Pubmed ID: 25194056
• Intranasal Delivery of Influenza RNP Adjuvanted with C-di-AMP Induces Strong Humoral and Cellular Immune Responses and Provides Protection Against Virus Challenge
  PloS One. 2014  |   Pubmed ID: 25140692
• A New Adjuvanted Nanoparticle-based H1N1 Influenza Vaccine Induced Antigen-specific Local Mucosal and Systemic Immune Responses After Administration into the Lung
  Vaccine. Apr, 2014  |   Pubmed ID: 24731807
• Purification of Hepatitis B Surface Antigen Virus-like Particles from Recombinant Pichia Pastoris and in Vivo Analysis of Their Immunogenic Properties
  Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. Dec, 2013  |   Pubmed ID: 24141044
• Vaccine Adjuvants: Key Tools for Innovative Vaccine Design
  Current Topics in Medicinal Chemistry. 2013  |   Pubmed ID: 24066891
• Development and Characterization of Attenuated Metabolic Mutants of Bordetella Bronchiseptica for Applications in Vaccinology
  Environmental Microbiology. Jan, 2013  |   Pubmed ID: 22676396
• Bis-(3',5')-cyclic Dimeric Adenosine Monophosphate: Strong Th1/Th2/Th17 Promoting Mucosal Adjuvant
  Vaccine. Jul, 2011  |   Pubmed ID: 21619907
• The Member of the Cyclic Di-nucleotide Family Bis-(3', 5')-cyclic Dimeric Inosine Monophosphate Exerts Potent Activity As Mucosal Adjuvant
  Vaccine. Mar, 2010  |   Pubmed ID: 20060510
• Immune Modulators with Defined Molecular Targets: Cornerstone to Optimize Rational Vaccine Design
  Advances in Experimental Medicine and Biology. 2009  |   Pubmed ID: 20047042
• The Toll-like Receptor 2/6 Ligand MALP-2 Reduces the Viability of Mycobacterium Tuberculosis in Murine Macrophages
  The Open Microbiology Journal. Apr, 2009  |   Pubmed ID: 19471610
• A Prime-boost Vaccination Protocol Optimizes Immune Responses Against the Nucleocapsid Protein of the SARS Coronavirus
  Vaccine. Dec, 2008  |   Pubmed ID: 18805454
• Immune Modulators with Defined Molecular Targets: Cornerstone to Optimize Rational Vaccine Design
  Human Vaccines. Jan-Feb, 2008  |   Pubmed ID: 18376145
• Oral Vaccination with Salmonella Enterica As a Cruzipain-DNA Delivery System Confers Protective Immunity Against Trypanosoma Cruzi
  Infection and Immunity. Jan, 2008  |   Pubmed ID: 17967857
• A Pegylated Derivative of Alpha-galactosylceramide Exhibits Improved Biological Properties
  Journal of Immunology (Baltimore, Md. : 1950). Aug, 2007  |   Pubmed ID: 17675464
• The Bacterial Second Messenger CdiGMP Exhibits Promising Activity As a Mucosal Adjuvant
  Clinical and Vaccine Immunology : CVI. Aug, 2007  |   Pubmed ID: 17567766
• The Bacterial Second Messenger Cyclic DiGMP Exhibits Potent Adjuvant Properties
  Vaccine. Feb, 2007  |   Pubmed ID: 17187906
• Intranasal Vaccination with Recombinant Outer Membrane Protein CD and Adamantylamide Dipeptide As the Mucosal Adjuvant Enhances Pulmonary Clearance of Moraxella Catarrhalis in an Experimental Murine Model
  Infection and Immunity. Apr, 2007  |   Pubmed ID: 17101651